November 21, 2009 — A drug used to treat erectile dysfunction may improve heart function in children and young adults with single ventricle congenital heart disease, according to researchers from The Children’s Hospital of Philadelphia.

November 24, 2009 – European CE mark clearance was granted this week for BridgePoint Medical’s coronary and peripheral chronic total occlusion (CTO) crossing system comprised of the CrossBoss CTO Crossing Catheter and the Stingray CTO Re-Entry System.

November 18, 2009 — A new, reversible blood thinner did not prove superior over placebo for its primary endpoints of heart attack and need for revascularization, but it did reduce in-stent blood clots. Researchers reported the findings in a late-breaking clinical trial presentation at the American Heart Association’s Scientific Sessions this week.

November 18, 2009 – Three platelet function tests identified patients who will have blood cells that remain sticky, increasing heart attack risk, despite being pretreated with two anti-clotting medications before coronary stenting. Researchers reported the findings at the American Heart Association’s Scientific Sessions this week.

November 18, 2009 – Patient enrollment was recently completed in the TRA 2 P-TIMI 50 clinical trial to study SCH 530348, an investigational anti-platelet protease activated receptor-1 (PAR-1) inhibitor.